Pylephlebitis as a Complication of Diverticulitis: CT Imaging, Clinical Diagnosis, and Evidence-Based Management of a Rare but Life-Threatening Portal Venous Infection
An Expert Review for Medical Imaging Professionals, Clinicians, and Healthcare AI Researchers
Keywords: Pylephlebitis, Portal Vein Thrombosis, Diverticulitis, CT Imaging, Portal Venous Gas, Mesenteric Venous Gas, Abdominal CT, Emergency Radiology, Diagnostic Imaging, Liver Infection, Sepsis, Healthcare AI, Medical Imaging, Clinical Decision Support, Artificial Intelligence in Radiology
Introduction
Among the infectious complications encountered in abdominal imaging, pylephlebitis remains one of the most challenging diagnoses because of its rarity, nonspecific clinical manifestations, and potentially devastating consequences. Although modern multidetector CT (MDCT) has dramatically improved diagnostic accuracy, delayed diagnosis continues to contribute to significant morbidity and mortality.
Pylephlebitis, also known as suppurative thrombophlebitis of the portal venous system, represents septic thrombosis involving the portal vein and/or its tributaries. The disease typically develops secondary to intra-abdominal infections, including diverticulitis, appendicitis, inflammatory bowel disease, necrotizing pancreatitis, and perforated bowel.
The present case illustrates one of the classic but uncommon imaging presentations of pylephlebitis complicating perforated sigmoid diverticulitis, emphasizing the indispensable role of multidetector CT in identifying both the primary source of infection and the secondary venous complications.
Unlike uncomplicated diverticulitis, pylephlebitis requires immediate recognition because progression may rapidly lead to portal vein thrombosis, hepatic abscess formation, bowel ischemia, septic shock, and death.
As radiologists increasingly collaborate with artificial intelligence (AI)-assisted diagnostic systems, understanding subtle CT findings becomes even more important. Modern AI algorithms are capable of highlighting vascular abnormalities, portal venous gas, mesenteric inflammation, and hepatic perfusion abnormalities, but expert interpretation remains essential.
Clinical Case Summary
A 46-year-old man presented to the emergency department with a 4-day history of fever and jaundice. Initial laboratory studies demonstrated leukocytosis and elevated aminotransferase levels, raising suspicion for acute cholangitis. Despite broad-spectrum antibiotic therapy, the patient's clinical condition failed to improve.
Contrast-enhanced abdominal CT subsequently revealed:
- Acute perforated sigmoid diverticulitis
- Mesenteric gas
- Gas extending from the inferior mesenteric vein into the splenic vein
- Portal venous gas reaching the portal vein confluence
- Perivascular inflammatory fat stranding
- Peripheral hepatic portal venous gas
These findings established the diagnosis of pylephlebitis secondary to perforated diverticulitis, leading to emergency Hartmann's procedure and targeted antibiotic therapy for Escherichia coli. The patient recovered uneventfully and was discharged on postoperative day 18.
Figure Placement
Figure 1. Coronal CT
Acute perforated sigmoid diverticulitis demonstrating focal bowel wall thickening, pericolic inflammatory fat stranding, and localized perforation (arrow), identifying the primary infectious source responsible for subsequent portal venous septic thrombosis.
Figure 2. Axial CT
Axial contrast-enhanced CT confirms severe sigmoid diverticulitis with surrounding inflammatory changes and localized perforation. The findings indicate complicated diverticulitis requiring urgent surgical evaluation.
Figure 3. Coronal CT
Coronal CT demonstrates mesenteric venous gas (red arrowhead), suggesting transmural bacterial invasion and septic propagation through the mesenteric venous circulation.
Figure 4. Axial CT
Axial CT clearly visualizes mesenteric gas adjacent to the inflamed sigmoid colon, an imaging feature strongly associated with severe complicated diverticulitis and septic thrombophlebitis.
Figure 5. Coronal CT
Coronal CT demonstrates gas extending from the inferior mesenteric vein through the splenic vein toward the portal vein, accompanied by inflammatory fat stranding around the inferior mesenteric vein and peripheral hepatic portal venous gas. These findings are diagnostic of pylephlebitis.
Pathophysiology
Pylephlebitis represents the end result of progressive bacterial invasion from an intra-abdominal infectious focus into the portal venous circulation.
The disease typically evolves through several sequential stages:
- Localized bowel inflammation
- Venous endothelial injury
- Septic thrombus formation
- Propagation into larger portal venous branches
- Hepatic dissemination
- Septic embolization
The polymicrobial nature of colonic infections promotes thrombus formation through activation of inflammatory cytokines, platelet aggregation, endothelial dysfunction, and bacterial biofilm formation.
Common pathogens include:
- Escherichia coli
- Bacteroides fragilis
- Streptococcus species
- Klebsiella pneumoniae
The presence of portal venous gas reflects bacterial fermentation and transmural migration of gas-forming organisms into mesenteric veins.
Continued expansion of septic thrombi may eventually compromise hepatic perfusion, resulting in hepatic abscesses or portal hypertension.
Epidemiology
Although pylephlebitis is considered an uncommon disease, its true incidence is probably underestimated because its early symptoms often mimic more common hepatobiliary disorders such as acute cholangitis or viral hepatitis. Before the advent of multidetector computed tomography (MDCT), most cases were diagnosed only during surgery or autopsy. Today, improved cross-sectional imaging has substantially increased recognition, yet the condition remains rare enough that many clinicians may encounter only one or two cases during their careers.
Recent systematic reviews indicate that diverticulitis has become the leading cause of pylephlebitis in adults, surpassing appendicitis in many developed countries. This shift parallels the increasing prevalence of diverticular disease in aging populations.
The majority of patients are between 40 and 70 years of age, with a modest male predominance. Several predisposing conditions increase susceptibility, including:
- Diverticulitis
- Acute appendicitis
- Necrotizing pancreatitis
- Inflammatory bowel disease
- Perforated bowel
- Hepatic cirrhosis
- Malignancy
- Diabetes mellitus
- Hypercoagulable disorders
- Recent abdominal surgery
Mortality has declined significantly over the past three decades because of earlier CT diagnosis, improved antimicrobial therapy, and advances in surgical management. Nevertheless, reported mortality still ranges from 10% to 25%, particularly when diagnosis is delayed or hepatic abscesses develop.
Clinical Presentation
One of the greatest diagnostic challenges is that pylephlebitis rarely presents with pathognomonic symptoms. Instead, patients typically exhibit manifestations of systemic infection combined with vague abdominal complaints.
Common Symptoms
- Persistent fever
- Chills
- Diffuse abdominal pain
- Right upper quadrant pain
- Nausea
- Vomiting
- Malaise
- Anorexia
- Jaundice
- Weight loss (occasionally)
In the present case, the patient presented with persistent fever and jaundice, while laboratory evaluation demonstrated leukocytosis and elevated aminotransferase levels, findings that initially suggested acute cholangitis rather than portal venous infection. The absence of clinical improvement despite broad-spectrum antibiotics prompted further investigation with contrast-enhanced CT, ultimately revealing perforated sigmoid diverticulitis complicated by pylephlebitis.
Laboratory Findings
Typical laboratory abnormalities include:
- Leukocytosis
- Elevated C-reactive protein
- Elevated ESR
- Mild anemia
- Elevated AST and ALT
- Elevated alkaline phosphatase
- Hyperbilirubinemia
- Positive blood cultures
The most frequently isolated organisms are:
- Escherichia coli
- Bacteroides fragilis
- Klebsiella pneumoniae
- Streptococcus anginosus
Because these laboratory findings are nonspecific, imaging remains the cornerstone of diagnosis.
Imaging Features
Contrast-enhanced multidetector CT is widely regarded as the imaging modality of choice because it simultaneously identifies:
- The primary intra-abdominal infection
- Septic thrombosis of the portal venous system
- Hepatic complications
- Extraintestinal inflammatory changes
- Surgical emergencies
Primary CT Findings
1. Complicated Sigmoid Diverticulitis
The inflamed sigmoid colon demonstrates:
- Segmental wall thickening
- Pericolic fat stranding
- Inflamed diverticula
- Extraluminal air
- Localized perforation
- Pericolic abscess (when present)
These findings establish the infectious source responsible for septic venous spread.
2. Mesenteric Venous Gas
Gas within the inferior mesenteric vein represents one of the most important imaging clues.
Unlike pneumoperitoneum, venous gas follows branching vascular structures toward the portal venous system.
In this patient, CT demonstrated gas within the mesenteric veins extending centrally, indicating bacterial invasion of the venous circulation.
3. Portal Venous Gas
Portal venous gas appears as multiple branching low-attenuation linear structures extending toward the peripheral liver.
Characteristic features include:
- Peripheral distribution
- Branching morphology
- Extension to within approximately 2 cm of the liver capsule
- Association with mesenteric venous gas
This pattern distinguishes portal venous gas from pneumobilia, which is centrally located near the hepatic hilum.
4. Septic Venous Thrombosis
The hallmark of pylephlebitis is septic thrombus formation within the portal venous system.
CT findings include:
- Intraluminal filling defects
- Venous enlargement
- Perivascular inflammatory fat stranding
- Vessel wall enhancement
- Gas within thrombosed veins
The current case demonstrated gas extending from the inferior mesenteric vein through the splenic vein toward the portal vein, accompanied by inflammatory fat stranding around the inferior mesenteric vein, findings highly characteristic of septic thrombophlebitis.
5. Hepatic Manifestations
Secondary hepatic findings may include:
- Portal venous gas
- Perfusion abnormalities
- Hepatic abscesses
- Segmental edema
- Transient hepatic attenuation differences
Peripheral portal venous gas is often the earliest manifestation before abscess formation develops.
Radiologic Differential Diagnosis
Radiologists must distinguish pylephlebitis from several entities with overlapping imaging appearances.
| Disease | Key Imaging Features | Distinguishing Characteristics |
|---|---|---|
| Acute Cholangitis | Biliary duct dilatation | No mesenteric venous gas |
| Bland Portal Vein Thrombosis | Filling defect only | No surrounding inflammation or gas |
| Mesenteric Ischemia | Pneumatosis intestinalis | Severe bowel ischemia predominates |
| Hepatic Abscess | Rim-enhancing lesions | May coexist with pylephlebitis |
| Pneumobilia | Central biliary gas | Gas confined to bile ducts |
| Septic Emboli | Multiple hepatic lesions | No identifiable bowel infection |
Among these, distinguishing portal venous gas from pneumobilia is particularly important. Portal venous gas extends to the liver periphery following portal venous branches, whereas pneumobilia remains centrally located within the biliary tree.
Diagnostic Approach
Early diagnosis requires integration of clinical suspicion, laboratory findings, and imaging.
Step 1: Clinical Assessment
Consider pylephlebitis in any patient with:
- Persistent fever
- Sepsis of unclear origin
- Diverticulitis
- Appendicitis
- Pancreatitis
- Elevated liver enzymes
- Failure to respond to antibiotics
Step 2: Laboratory Evaluation
Recommended investigations include:
- Complete blood count
- Liver function tests
- Blood cultures
- Coagulation profile
- Inflammatory markers
- Serum lactate
Step 3: Imaging
Preferred modalities:
- Contrast-enhanced abdominal CT (first-line)
- Doppler ultrasonography (adjunctive)
- MRI with MR venography (selected cases)
Step 4: Microbiologic Confirmation
Blood cultures should be obtained before antibiotic administration whenever feasible, as bacteremia is common and guides targeted antimicrobial therapy.
In this case, Escherichia coli was isolated from culture, and the patient improved following emergency Hartmann's procedure combined with targeted antibiotic therapy.
Treatment
Successful treatment of pylephlebitis depends on three fundamental principles:
- Rapid control of the primary intra-abdominal infection
- Prompt administration of broad-spectrum intravenous antibiotics
- Early recognition and management of portal venous thrombosis and its complications
Unlike uncomplicated diverticulitis, pylephlebitis represents a systemic septic process. Delayed intervention markedly increases the risk of hepatic abscesses, bowel ischemia, septic shock, and multi-organ failure.
Initial Stabilization
The initial management follows standard sepsis protocols.
Hemodynamic Support
Patients presenting with septic physiology should immediately receive:
- Intravenous crystalloid resuscitation
- Electrolyte correction
- Blood culture collection before antibiotics
- Continuous monitoring
- Early vasopressor therapy when indicated
Antibiotic Therapy
Because pylephlebitis is usually polymicrobial, empiric antimicrobial therapy should cover:
- Gram-negative organisms
- Anaerobic bacteria
- Enteric streptococci
Recommended empiric regimens include:
- Piperacillin–tazobactam
- Ceftriaxone plus metronidazole
- Cefepime plus metronidazole
- Carbapenems for severe sepsis
- Meropenem in critically ill patients
Therapy should later be adjusted according to blood culture results.
The present patient demonstrated Escherichia coli infection and improved following culture-directed antibiotic therapy after emergency surgery.
Treatment generally continues for 4–6 weeks, depending on the severity of thrombosis and the presence of hepatic abscesses.
Surgical Management
The underlying infectious source must always be addressed.
Possible interventions include:
- Hartmann procedure
- Sigmoid colectomy
- Appendectomy
- Percutaneous abscess drainage
- Damage-control surgery in septic shock
In this case, emergency Hartmann's procedure successfully eliminated the septic focus and prevented further progression of portal venous infection.
Role of Anticoagulation
One of the most debated issues in pylephlebitis management concerns anticoagulation.
Potential Benefits
- Prevent thrombus propagation
- Improve venous recanalization
- Reduce chronic portal hypertension
- Decrease mesenteric ischemia risk
Potential Risks
- Gastrointestinal bleeding
- Postoperative hemorrhage
- Increased procedural complications
Current evidence does not recommend routine anticoagulation for every patient.
Instead, anticoagulation is generally reserved for:
- Extensive portal vein thrombosis
- Mesenteric vein extension
- Hypercoagulable disorders
- Progressive thrombosis despite antibiotics
- Persistent bacteremia
Interestingly, the patient in this report recovered completely without anticoagulation, highlighting that individualized management remains essential.
Prognosis
The prognosis of pylephlebitis has improved dramatically owing to earlier diagnosis with multidetector CT, more effective antibiotics, and timely surgical intervention.
Favorable Prognostic Factors
- Early CT diagnosis
- Prompt source control
- Appropriate antimicrobial therapy
- Limited thrombus burden
- Absence of liver abscess
Poor Prognostic Factors
- Delayed diagnosis
- Septic shock
- Diffuse portal vein thrombosis
- Multiple hepatic abscesses
- Immunosuppression
- Persistent bacteremia
Potential complications include:
- Hepatic abscess
- Chronic portal hypertension
- Cavernous transformation of the portal vein
- Bowel ischemia
- Liver infarction
- Recurrent sepsis
- Death
Fortunately, this patient experienced an excellent postoperative recovery and was discharged on postoperative day 18.
Artificial Intelligence in CT Diagnosis of Pylephlebitis
Artificial intelligence is rapidly transforming emergency abdominal imaging, particularly in detecting subtle vascular and inflammatory abnormalities.
Current AI Applications
Automated Detection of Portal Venous Gas
Deep learning algorithms can identify:
- Branching hepatic gas collections
- Portal venous air
- Mesenteric venous gas
- Hepatic perfusion abnormalities
These findings may be overlooked during busy emergency workflows.
Automated Segmentation of Portal Veins
AI-assisted vessel segmentation enables:
- Three-dimensional visualization
- Quantification of thrombus volume
- Monitoring of treatment response
- Surgical planning
Detection of Complicated Diverticulitis
Modern convolutional neural networks can detect:
- Inflamed diverticula
- Bowel wall thickening
- Perforation
- Extraluminal air
- Pericolic abscess
Integration of these findings with portal venous abnormalities could significantly improve early diagnosis.
Clinical Decision Support Systems
Future AI platforms will likely integrate:
- CT findings
- Laboratory results
- Electronic health records
- Blood culture data
- Sepsis prediction models
to generate real-time diagnostic probabilities for rare conditions such as pylephlebitis.
Clinical Pearls
Pearl 1
Persistent fever despite antibiotic therapy should prompt repeat imaging.
Pearl 2
Portal venous gas is not synonymous with bowel ischemia.
When associated with diverticulitis, it should strongly suggest septic thrombophlebitis.
Pearl 3
The combination of:
- Sigmoid diverticulitis
- Mesenteric venous gas
- Portal venous gas
- Perivascular fat stranding
is highly suggestive of pylephlebitis.
Pearl 4
Contrast-enhanced CT remains the diagnostic gold standard.
Pearl 5
Early multidisciplinary collaboration among radiologists, surgeons, infectious disease specialists, and emergency physicians significantly improves outcomes.
Key Take-Home Messages
- Pylephlebitis is a rare but life-threatening septic thrombosis of the portal venous system.
- Complicated sigmoid diverticulitis is now one of the leading causes in adults.
- Contrast-enhanced CT is the imaging modality of choice for identifying both the primary infectious source and septic venous thrombosis.
- Characteristic imaging findings include mesenteric venous gas, portal venous gas, venous filling defects, and inflammatory fat stranding.
- Early antibiotic therapy and prompt surgical source control are the cornerstones of successful management.
- Artificial intelligence has the potential to enhance early detection of subtle vascular findings but should complement—not replace—expert radiologic interpretation.
Conclusion
Pylephlebitis represents one of the most important vascular complications of complicated diverticulitis and remains a diagnostic challenge because of its rarity and nonspecific clinical presentation. This case highlights how multidetector CT can reveal the full spectrum of disease—from perforated sigmoid diverticulitis and mesenteric venous gas to septic thrombosis extending into the portal venous system—allowing timely surgical intervention and targeted antimicrobial therapy.
For radiologists, recognizing these characteristic imaging findings is critical, as early diagnosis directly influences survival and helps prevent devastating complications such as hepatic abscesses, portal hypertension, bowel ischemia, and sepsis. As artificial intelligence continues to evolve, AI-assisted detection of portal venous gas, venous thrombosis, and complicated diverticulitis is likely to become an important adjunct in emergency abdominal imaging, further improving diagnostic confidence and patient outcomes.
This case also underscores a broader lesson in emergency medicine: persistent systemic infection that fails to respond to conventional therapy should always prompt a careful reassessment of the diagnosis. When CT demonstrates gas within the mesenteric or portal venous system in the setting of intra-abdominal infection, pylephlebitis must be considered immediately, and rapid multidisciplinary management should follow.
_____________________________________________________________________
Quiz
Question 1
A 46-year-old man presents with persistent fever, jaundice, and leukocytosis that do not improve despite broad-spectrum antibiotics. Contrast-enhanced CT demonstrates perforated sigmoid diverticulitis, mesenteric venous gas, and gas extending from the inferior mesenteric vein into the portal venous system.
What is the most likely diagnosis?
A. Acute cholangitis
B. Pyelonephritis
C. Acute pancreatitis
D. Pancreatic adenocarcinoma
E. Pylephlebitis
Correct Answer
✅ E. Pylephlebitis
Explanation
Pylephlebitis is a septic thrombophlebitis involving the portal venous system that usually develops secondary to intra-abdominal infections such as diverticulitis or appendicitis. The combination of perforated diverticulitis, mesenteric venous gas, portal venous gas, and inflammatory changes surrounding the inferior mesenteric vein is highly characteristic.
Question 2
Which CT finding most strongly supports the diagnosis of pylephlebitis rather than uncomplicated diverticulitis?
A. Colonic wall thickening
B. Pericolic inflammatory fat stranding
C. Diverticula within the sigmoid colon
D. Gas within the inferior mesenteric vein extending into the portal vein
E. Mild ascites
Correct Answer
✅ D. Gas within the inferior mesenteric vein extending into the portal vein
Explanation
While bowel wall thickening and pericolic fat stranding are common findings in uncomplicated diverticulitis, gas within the mesenteric and portal venous system strongly suggests septic thrombophlebitis (pylephlebitis) and should immediately prompt aggressive treatment.
Question 3
Which microorganism is most commonly associated with pylephlebitis secondary to diverticulitis?
A. Staphylococcus aureus
B. Escherichia coli
C. Mycobacterium tuberculosis
D. Candida albicans
E. Enterococcus faecalis
Correct Answer
✅ B. Escherichia coli
Explanation
Pylephlebitis is usually polymicrobial. The most frequently isolated pathogens are:
- Escherichia coli
- Bacteroides fragilis
- Klebsiella pneumoniae
- Streptococcus species
In the present case, Escherichia coli was isolated from culture following emergency surgery.
Frequently Asked Questions (FAQ)
1. Is pylephlebitis a medical emergency?
Yes. It is a rare but life-threatening septic thrombosis of the portal venous system. Delayed diagnosis can result in liver abscesses, bowel ischemia, septic shock, portal hypertension, and death.
2. Why is contrast-enhanced CT considered the gold standard?
Contrast-enhanced CT simultaneously identifies:
- The primary infectious source (e.g., diverticulitis)
- Septic thrombosis within the portal venous system
- Portal venous gas
- Mesenteric venous gas
- Hepatic complications
- Surgical emergencies
3. Does every patient require anticoagulation?
No. Current evidence does not support routine anticoagulation for all patients. The decision should be individualized based on thrombus extent, hypercoagulable conditions, progression despite antibiotics, and bleeding risk.
4. Can artificial intelligence diagnose pylephlebitis?
AI can assist by detecting:
- Portal venous gas
- Mesenteric venous gas
- Portal vein thrombosis
- Complicated diverticulitis
- Hepatic perfusion abnormalities
However, expert radiologist interpretation remains essential for integrating imaging findings with clinical and laboratory data.
5. What is the most important imaging clue?
The presence of gas extending through the mesenteric veins into the portal venous system, particularly when associated with diverticulitis, is one of the most characteristic CT findings of pylephlebitis.
Medical Disclaimer
This article is intended for educational purposes only and does not constitute medical advice. Patients should consult qualified healthcare professionals for diagnosis and treatment.
________________________________________________________________
Recommended Reading
- Kanellopoulou T., et al., "Pylephlebitis: An overview of non-cirrhotic cases and factors related to outcome," Scand. J. Infect. Dis., vol. 42, no. 11–12, pp. 804–811, 2010. DOI: https://doi.org/10.3109/00365548.2010.508464
- Choudhry A. J., et al., "Pylephlebitis: A Review of 95 Cases," J. Gastrointest. Surg., 2016. DOI: https://doi.org/10.1007/s11605-016-3108-9
- Plemmons R. M., et al., "Septic thrombophlebitis of the portal vein (Pylephlebitis)," Medicine (Baltimore), 1995. DOI: https://doi.org/10.1097/00005792-199509000-00002
- Condat B., et al., "Current concepts in portal vein thrombosis," Hepatology, 2000. DOI: https://doi.org/10.1053/jhep.2000.19146
- Kumar S., et al., "Mesenteric venous thrombosis," N. Engl. J. Med., 2001. DOI: https://doi.org/10.1056/NEJMra010076
- Acosta S., Alhadad A., Svensson P., "Epidemiology, Risk and Prognosis in Mesenteric Venous Thrombosis," Br. J. Surg., 2008. DOI: https://doi.org/10.1002/bjs.6319
- Heye T., et al., "Imaging of portal venous gas," Radiographics, 2012. DOI: https://doi.org/10.1148/rg.324115127
- Gore R. M., et al., "Textbook of Gastrointestinal Radiology," 5th ed., Elsevier, 2021. (Comprehensive reference on portal venous disease and abdominal CT interpretation.)
Comments
Post a Comment